Lassa fever cost-effectiveness of therapy

Jump to navigation Jump to search

Lassa fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Lassa fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lassa fever cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lassa fever cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lassa fever cost-effectiveness of therapy

CDC on Lassa fever cost-effectiveness of therapy

Lassa fever cost-effectiveness of therapy in the news

Blogs on Lassa fever cost-effectiveness of therapy

Directions to Hospitals Treating Lassa fever

Risk calculators and risk factors for Lassa fever cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Overview

Adequate preventive measures must be implemented to curtail the spread of Lassa fever. Cost effective therapy if was properly implemented 5 decades ago in Lassa would have prevented devastating consequences of the disease pervading now.

Cost effectiveness

  • Cost effective therapy would encourage the patient to seek medical care immediately if they suspect illness especially in the lower economic strata.
  • Other ways of cost effective management of Lassa fever include the following:
  • Effective rodent control.
  • Prompt isolation of the patient.
  • Proposed vaccinations for visitors from the United Nations, non-governmental organisations, and business communities to the endemic areas.[1]

References

  1. Richmond JK, Baglole DJ (2003). "Lassa fever: epidemiology, clinical features, and social consequences". BMJ. 327 (7426): 1271–5. doi:10.1136/bmj.327.7426.1271. PMC 286250. PMID 14644972.


Template:WikiDoc Sources